This page is the continuation of references in support of Section 6G
REFERENCES
Alizadeh, A.A., Ross, D.T., Perou, C.M., van de Rijn, M. (2001). Towards a novel classification of human malignancies based on gene expression patterns. J. Pathol 195, 41–52. (Retrieved 19th Feb 2015): http://onlinelibrary.wiley.com/doi/10.1002/path.889/abstract;jsessionid=9863A22FF62CA10EE7AE6EC1F456D211.f04t04
Alphy RJ, Sreelekha TT. (2012) Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer. Lung Cancer International: Article ID 729532 (Retrieved 19th Feb 2015): http://www.hindawi.com/journals/lci/2012/729532/
Awad MM, Shaw AT.(2014) ALK Inhibitors in Non–Small Cell Lung Cancer: Crizotinib and Beyond. Clin Adv Hematol Oncol. Jul; 12(7): 429–439. (Retrieved 29th April 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215402/
Clark GM. (2007) Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib. Molecular Oncology: Volume 1, Issue 4: Pages 406–412. (Retrieved 29th April 2015): http://www.sciencedirect.com/science/article/pii/S1574789107001020
Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV. et al. (2002) p63 Expression Profiles in Human Normal and Tumor Tissues. Clin Cancer Res February 8;494 (Retrieved 28th April 2015): https://www.ncbi.nlm.nih.gov/pubmed/11839669
Gazdar AF, Schiller JH. (2011) Predictive and Prognostic Factors for Non–Small Cell Lung Cancer—Potholes in the Road to the Promised Land. JNCI J Natl Cancer Inst (2011) 103 (24): 1810-1811. (Retrieved 29th April 2015): http://jnci.oxfordjournals.org/content/103/24/1810.full
Goldstein, N.S., Hewitt, S.M., Taylor, C.R., et al. (2007). Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol 15, 124–33. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/17525622?dopt=Abstract
Lindeman NI, Cagle PT, Beasley MB, et al. (2013). Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med 137(6),828-860. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162344/
Weinstein IB. (2002). Addiction to oncogenes: the Achilles heel of cancer. Science 297 63–64. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/12098689
